Zacks Investment Research upgraded shares of INVACARE CORP (IVC) from UNDERPERFORM to NEUTRAL on November 06, 2012, with a target price of $14.40.
Invacare Corporation is the world's leading manufacturer and distributor of non-acute health care products based upon its distribution channels, the breadth of its product line and sales. The company designs, manufactures and distributes an extensive line of health care products for the non-acute care environment including the home health care, retail and extended care markets. The company's products are sold through its world-wide distribution network byits sales force, telemarketing employees and various organizations of independent manufacturer's representatives.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on INVACARE CORP (IVC),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment